JP2025512357A5 - - Google Patents
Info
- Publication number
- JP2025512357A5 JP2025512357A5 JP2024560230A JP2024560230A JP2025512357A5 JP 2025512357 A5 JP2025512357 A5 JP 2025512357A5 JP 2024560230 A JP2024560230 A JP 2024560230A JP 2024560230 A JP2024560230 A JP 2024560230A JP 2025512357 A5 JP2025512357 A5 JP 2025512357A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- peptide
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263331534P | 2022-04-15 | 2022-04-15 | |
| US63/331,534 | 2022-04-15 | ||
| PCT/US2023/065778 WO2023201336A2 (en) | 2022-04-15 | 2023-04-14 | Humanized multivalent protein conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512357A JP2025512357A (ja) | 2025-04-17 |
| JP2025512357A5 true JP2025512357A5 (enExample) | 2026-04-21 |
Family
ID=88330387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560230A Pending JP2025512357A (ja) | 2022-04-15 | 2023-04-14 | ヒト化多価タンパク質コンジュゲート |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230406916A1 (enExample) |
| EP (1) | EP4508078A2 (enExample) |
| JP (1) | JP2025512357A (enExample) |
| KR (1) | KR20250007543A (enExample) |
| CN (1) | CN119213019A (enExample) |
| AU (1) | AU2023254257A1 (enExample) |
| CA (1) | CA3255622A1 (enExample) |
| TW (1) | TW202405007A (enExample) |
| WO (1) | WO2023201336A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102954778B1 (ko) | 2018-03-09 | 2026-04-20 | 발리터 인코포레이티드 | 관절 염증의 지속적인 관절내 치료를 위한 다가 펩티드 컨쥬게이트 |
| WO2026112108A1 (en) * | 2024-11-20 | 2026-05-28 | Valitor, Inc. | Multivalent protein conjugates |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2706425A1 (en) * | 2007-11-27 | 2009-06-04 | Ablynx N.V. | Method for obtaining polypeptide constructs comprising two or more single domain antibodies |
| US20190142953A1 (en) * | 2016-05-10 | 2019-05-16 | Massachusetts Institute Of Technology | Dendrimer-Drug Conjugates, Hydrogel Compositions, and Methods |
| KR102954778B1 (ko) * | 2018-03-09 | 2026-04-20 | 발리터 인코포레이티드 | 관절 염증의 지속적인 관절내 치료를 위한 다가 펩티드 컨쥬게이트 |
| CN119306844A (zh) * | 2018-09-25 | 2025-01-14 | 哈普恩治疗公司 | Dll3结合蛋白及使用方法 |
| TW202519557A (zh) * | 2019-09-04 | 2025-05-16 | 美商建南德克公司 | Cd8 結合劑及其用途 |
| CN113980130B (zh) * | 2020-07-27 | 2023-07-21 | 湖南远泰生物技术有限公司 | 人源化cd37和双特异性cd19-人源化cd37 car-t细胞 |
-
2023
- 2023-04-14 CA CA3255622A patent/CA3255622A1/en active Pending
- 2023-04-14 US US18/300,823 patent/US20230406916A1/en active Pending
- 2023-04-14 AU AU2023254257A patent/AU2023254257A1/en active Pending
- 2023-04-14 CN CN202380034460.3A patent/CN119213019A/zh active Pending
- 2023-04-14 WO PCT/US2023/065778 patent/WO2023201336A2/en not_active Ceased
- 2023-04-14 TW TW112114052A patent/TW202405007A/zh unknown
- 2023-04-14 EP EP23789178.3A patent/EP4508078A2/en active Pending
- 2023-04-14 KR KR1020247037197A patent/KR20250007543A/ko active Pending
- 2023-04-14 JP JP2024560230A patent/JP2025512357A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2577134C2 (ru) | Улучшенные аминокислотные последовательности, направленные против респираторно-синцитиального вируса человека (hrsv), и полипептиды, включающие такие последовательности, для профилактики и/или лечения инфекций дыхательных путей | |
| JP2025000642A5 (enExample) | ||
| EP2430049B1 (fr) | Anticorps humanises spécifiques de la forme protofibrillaire du peptide béta-amyloide | |
| JP2014518064A5 (enExample) | ||
| US8936785B2 (en) | scFv antibodies which pass epithelial and/or endothelial layers | |
| CA3153860A1 (en) | Engineered antibodies as molecular degraders through cellular receptors | |
| EP2447281B1 (en) | Novel anti-PLGF antibody | |
| JP2011212022A (ja) | Ｄｋｋ−１に対する抗体 | |
| JP2005523946A5 (enExample) | ||
| RU2011110169A (ru) | Антитела против ccr2 | |
| CN102924597A (zh) | 抑制TNFα的稳定和可溶的抗体 | |
| HU230553B1 (hu) | Humán tumor nekrózis faktor alfa specifikus antitest molekulák és alkalmazásuk | |
| JP2018505177A5 (enExample) | ||
| RU2019140602A (ru) | АНТИ-GARP-TGF-β-АНТИТЕЛА | |
| JP2011506483A5 (enExample) | ||
| RU2018119014A (ru) | АНТИТЕЛА ПРОТИВ Нtr1 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| JP2021515037A5 (enExample) | ||
| JP2025514437A5 (enExample) | ||
| JP2019503706A5 (enExample) | ||
| JP2018530574A5 (enExample) | ||
| JP2018529661A5 (enExample) | ||
| JP2025512364A5 (enExample) | ||
| JP2021523881A5 (enExample) | ||
| JP2012506237A (ja) | Ｄｃ−ｓｉｇｎに対する結合特異性をもつリガンド | |
| ES2985731T3 (es) | Tratamiento de exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica mediante antagonismo de IL-20R |